...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM

This is filed on SEDAR:

Date: October 7, 2020

800, 324-8th Avenue SW

Calgary, AB T2P 2Z2

www.computershare.com

To: All Canadian Securities Regulatory Authorities

Subject: Zenith Capital Corp.

Dear Sir/Madam:

We advise of the following with respect to the upcoming Meeting of Security Holders for the subject

Issuer:

Meeting Type : Annual and Special Meeting

Record Date for Notice of Meeting : November 02, 2020

Record Date for Voting (if applicable) : November 02, 2020

Beneficial Ownership Determination Date : November 02, 2020

Meeting Date : December 22, 2020

Meeting Location (if available) : Virtual

Issuer sending proxy related materials directly to NOBO: No

Issuer paying for delivery to OBO: No

Notice and Access (NAA) Requirements:

NAA for Beneficial Holders Yes

Beneficial Holders Stratification Criteria: Not Applicable

NAA for Registered Holders No

Voting Security Details:

Description CUSIP Number ISIN

COMMON SHARES 98935N103 CA98935N1033

Sincerely,

Computershare

Agent for Zenith Capital Corp.

Share
New Message
Please login to post a reply